|
|
|
By Susan Sharfstein, University at Albany | Let's dig into cell line selection approaches, transposons to increase copy number for the gene of interest, and targeted integration to rapidly obtain high-productivity clones. |
|
|
|
By M. Witcher, Ph.D., biopharma operations subject matter expert | This overview article takes a look at each product development stage for biopharmaceuticals to illuminate when continuous manufacturing can satisfy important business drivers. |
|
|
|
|
|
| Impact Of Immunogenicity On Efficacy And Safety Of Biosimilars | White Paper | Prepared by Adam Tuszyner, Mabion | The presence of anti-drug antibodies (ADAs) can affect the effectiveness and safety of biologic drugs. Read why regulatory agencies emphasize the need for extensive immunogenicity evaluation in biosimilar development. |
|
|
|
|
|
|
|
|
